217 related articles for article (PubMed ID: 37503918)
1. Clinical characteristics of familial and sporadic pediatric cerebral cavernous malformations and outcomes.
Jaman E; Abdallah HM; Zhang X; Greene S
J Neurosurg Pediatr; 2023 Oct; 32(4):506-513. PubMed ID: 37503918
[TBL] [Abstract][Full Text] [Related]
2. Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI.
Dammann P; Wrede K; Zhu Y; Matsushige T; Maderwald S; Umutlu L; Quick HH; Hehr U; Rath M; Ladd ME; Felbor U; Sure U
J Neurosurg; 2017 Feb; 126(2):570-577. PubMed ID: 27153162
[TBL] [Abstract][Full Text] [Related]
3. Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype.
Petersen TA; Morrison LA; Schrader RM; Hart BL
AJNR Am J Neuroradiol; 2010 Feb; 31(2):377-82. PubMed ID: 19833796
[TBL] [Abstract][Full Text] [Related]
4. Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation.
Weinsheimer S; Nelson J; Abla AA; Ko NU; Tsang C; Okoye O; Zabramski JM; Akers A; Zafar A; Mabray MC; Hart BL; Morrison L; McCulloch CE; Kim H;
J Am Heart Assoc; 2023 Feb; 12(3):e027572. PubMed ID: 36695309
[TBL] [Abstract][Full Text] [Related]
5. Multiple cerebral cavernous malformations: Clinical course of confirmed, assumed and non-familial disease.
Santos AN; Rauschenbach L; Saban D; Chen B; Darkwah Oppong M; Herten A; Gull HH; Rieß C; Deuschl C; Schmidt B; Jabbarli R; Wrede KH; Zhu Y; Frank B; Sure U; Dammann P
Eur J Neurol; 2022 May; 29(5):1427-1434. PubMed ID: 35060255
[TBL] [Abstract][Full Text] [Related]
6. Relevance of CCM gene polymorphisms for clinical management of sporadic cerebral cavernous malformations.
Rinaldi C; Bramanti P; Scimone C; Donato L; Alafaci C; D'Angelo R; Sidoti A
J Neurol Sci; 2017 Sep; 380():31-37. PubMed ID: 28870584
[TBL] [Abstract][Full Text] [Related]
7. Cerebellar cavernous malformation in pediatric patients: defining clinical, neuroimaging, and therapeutic characteristics.
Knerlich-Lukoschus F; Steinbok P; Dunham C; Cochrane DD
J Neurosurg Pediatr; 2015 Sep; 16(3):256-66. PubMed ID: 26053436
[TBL] [Abstract][Full Text] [Related]
8. Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation.
Choquet H; Nelson J; Pawlikowska L; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H
Cerebrovasc Dis; 2014; 37(1):57-63. PubMed ID: 24401931
[TBL] [Abstract][Full Text] [Related]
9. CCM2 gene polymorphisms in Italian sporadic patients with cerebral cavernous malformation: a case-control study.
D'Angelo R; Scimone C; Rinaldi C; Trimarchi G; Italiano D; Bramanti P; Amato A; Sidoti A
Int J Mol Med; 2012 Jun; 29(6):1113-20. PubMed ID: 22378217
[TBL] [Abstract][Full Text] [Related]
10. Natural Course of Cerebral Cavernous Malformations in Children: A Five-Year Follow-Up Study.
Santos AN; Rauschenbach L; Saban D; Chen B; Herten A; Dinger TF; Li Y; Tippelt S; Della Marina A; Dohna-Schwake C; Schmidt B; Jabbarli R; Wrede KH; Sure U; Dammann P
Stroke; 2022 Mar; 53(3):817-824. PubMed ID: 34706565
[TBL] [Abstract][Full Text] [Related]
11. Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial.
Lanfranconi S; Scola E; Bertani GA; Zarino B; Pallini R; d'Alessandris G; Mazzon E; Marino S; Carriero MR; Scelzo E; Faragò G; Castori M; Fusco C; Petracca A; d'Agruma L; Tassi L; d'Orio P; Lampugnani MG; Nicolis EB; Vasamì A; Novelli D; Torri V; Meessen JMTA; Al-Shahi Salman R; Dejana E; Latini R;
Trials; 2020 May; 21(1):401. PubMed ID: 32398113
[TBL] [Abstract][Full Text] [Related]
12. Pediatric cerebral cavernous malformations and stereotactic radiosurgery: an analysis of 50 cases from a multicentric study.
Mantziaris G; Dumot C; Pikis S; Peker S; Samanci Y; Ardor GD; Nabeel AM; Reda WA; Tawadros SR; Abdel Karim K; El-Shehaby AMN; Emad Eldin RM; Elazzazi AH; Sheehan D; Sheehan K; Martínez Moreno N; Martínez Álvarez R; Liscak R; May J; Tripathi M; Rajput A; Kumar N; Kaur R; Alzate JD; Kondziolka D; Dayawansa S; Sheehan JP
J Neurosurg Pediatr; 2024 Apr; 33(4):315-322. PubMed ID: 38181511
[TBL] [Abstract][Full Text] [Related]
13. Zabramski classification in predicting the occurrence of symptomatic intracerebral hemorrhage in sporadic cerebral cavernous malformations.
Wang J; Yu QF; Huo R; Sun YF; Jiao YM; Xu HY; Zhang JZ; Zhao SZ; He QH; Wang S; Zhao JZ; Cao Y
J Neurosurg; 2024 Mar; 140(3):792-799. PubMed ID: 37724811
[TBL] [Abstract][Full Text] [Related]
14. Cerebral Cavernous Malformations, Developmental Venous Anomaly, and Its Coexistence: A Review.
Idiculla PS; Gurala D; Philipose J; Rajdev K; Patibandla P
Eur Neurol; 2020; 83(4):360-368. PubMed ID: 32731220
[TBL] [Abstract][Full Text] [Related]
15. Sporadic cerebral cavernous malformations: report of further mutations of CCM genes in 40 Italian patients.
D'Angelo R; Alafaci C; Scimone C; Ruggeri A; Salpietro FM; Bramanti P; Tomasello F; Sidoti A
Biomed Res Int; 2013; 2013():459253. PubMed ID: 24058906
[TBL] [Abstract][Full Text] [Related]
16. Genetics of cerebral cavernous malformations: current status and future prospects.
Choquet H; Pawlikowska L; Lawton MT; Kim H
J Neurosurg Sci; 2015 Sep; 59(3):211-20. PubMed ID: 25900426
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.
Denier C; Labauge P; Brunereau L; Cavé-Riant F; Marchelli F; Arnoult M; Cecillon M; Maciazek J; Joutel A; Tournier-Lasserve E; ;
Ann Neurol; 2004 Feb; 55(2):213-20. PubMed ID: 14755725
[TBL] [Abstract][Full Text] [Related]
18. Cavernous Malformations to Be Investigated for Familiarity: The Role of Ki67 MIB1.
Maiuri F; Mariniello G; Corvino S; Somma T; Guadagno E; Teodonno G; Del Basso De Caro M; Cappabianca P
World Neurosurg; 2021 Nov; 155():e75-e82. PubMed ID: 34389524
[TBL] [Abstract][Full Text] [Related]
19. KRIT1 Gene in Patients with Cerebral Cavernous Malformations: Clinical Features and Molecular Characterization of Novel Variants.
Ricci C; Cerase A; Riolo G; Manasse G; Battistini S
J Mol Neurosci; 2021 Sep; 71(9):1876-1883. PubMed ID: 33651268
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
